Insight Molecular Diagnostics Inc. Common Stock (NASDAQ: IMDX) last traded at $4.34, up 0.93% on the session. The quote above updates while this page is open; the figures below are drawn from Insight Molecular Diagnostics Inc. Common Stock’s own filings and are restated only when a new one is published.
Insight Molecular Diagnostics Inc. Common Stock trades on NASDAQ under the ticker IMDX. Its market capitalisation is $142.02 million.
Valuation measures for Insight Molecular Diagnostics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $142.02M |
|---|---|
| Enterprise value | $175.01M |
| Price / sales | 85.04 |
| Beta | 2.45 |
Trailing-twelve-month figures tagged in Insight Molecular Diagnostics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.67M |
|---|---|
| Net income (TTM) | -$49.36M |
| EPS (TTM) | -$1.52 |
| Gross margin | 48.32% |
| Operating margin | -3011.86% |
| Cash | $17.76M |
Range and volume for IMDX over the past 52 weeks.
| 52-week high | $8.51 |
|---|---|
| 52-week low | $2.33 |
| Volume | 38.0K |
| Average volume | 236.1K |
| Previous close | $4.30 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.